multiple sclerosis
Item
clinically or laboratory-supported definite multiple sclerosis
boolean
C0026769 (UMLS CUI [1])
neurological status
Item
neurologically stable for at least 30 days prior to entry expanded disability status scale score no greater than 5
boolean
C0746866 (UMLS CUI [1])
C3830336 (UMLS CUI [2])
relapses
Item
at least 2 documented relapses within 2 years prior to entry onset of first relapse at least 1 year prior to randomization
boolean
C0277556 (UMLS CUI [1])
biologic therapy
Item
biologic therapy: no prior copolymer 1
boolean
C0005527 (UMLS CUI [1])
immunosuppressive therapy
Item
immunosuppressive therapy: no prior cytotoxic immunosuppressives, i.e.: azathioprine cyclophosphamide cyclosporine at least 30 days since corticosteroids
boolean
C0021079 (UMLS CUI [1])
C0004482 (UMLS CUI [2])
C0010583 (UMLS CUI [3])
C0010592 (UMLS CUI [4])
radiotherapy
Item
radiotherapy: no prior lymphoid irradiation
boolean
C0024230 (UMLS CUI [1])
patient characteristics
Item
not hiv or htlv-i seropositive no insulin-dependent diabetes mellitus no lyme disease no requirement for aspirin or chronic nonsteroidal anti-inflammatory drugs no pregnant or nursing women adequate contraception required of fertile women
boolean
C0019682 (UMLS CUI [1])
C0020094 (UMLS CUI [2])
C0011854 (UMLS CUI [3])
C0024198 (UMLS CUI [4])
C0003211 (UMLS CUI [5])
C0032961 (UMLS CUI [6])
C0006147 (UMLS CUI [7])
C1999124 (UMLS CUI [8])